Colistin, Meropenem-Vaborbactam, Imipenem-Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2

被引:0
作者
Forstner, Patrick [1 ]
Fuchs, Lisa [1 ]
Luxner, Josefa [1 ]
Grisold, Andrea [1 ]
Steinmetz, Ivo [1 ]
Dichtl, Karl [1 ]
机构
[1] Med Univ Graz, Diagnost & Res Inst Hyg Microbiol & Environm Med, A-8010 Graz, Austria
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 11期
关键词
VITEK; 2; AST-XN24; gradient test; Pseudomonas aeruginosa; Acinetobacter baumannii complex; Enterobacterales; carbapenem-resistant organism; colistin; eravacycline; meropenem-vaborbactam; imipenem-relebactam; IN-VITRO ACTIVITY; ACINETOBACTER-BAUMANNII; ENTEROBACTERIACEAE; SURVEILLANCE; PNEUMONIAE; ETEST;
D O I
10.3390/antibiotics13111062
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives. This study aimed to evaluate and compare the performance of different assays for antimicrobial susceptibility testing (AST) and minimum inhibitory concentration (MIC) determination for reserve antibiotics in carbapenem-resistant Enterobacterales (CREs), Pseudomonas aeruginosa (CRPAs), and Acinetobacter baumannii (CRABs). Methods. An analysis was conducted on 100 consecutive isolates: 50 CREs, 35 CRPAs, and 15 CRABs. Sensititre broth microdilution was used as a reference standard to evaluate the performance of VITEK 2 card AST-XN24 (bioM & eacute;rieux), the respective gradient tests (bioM & eacute;rieux), and UMIC colistin broth microdilution test strips (Bruker Daltonics). Errors, essential agreement (EA), and categorical agreement of MICs for colistin (COL), meropenem-vaborbactam (MVB), imipenem-relebactam (IRL), and eravacycline (ERV) were assessed. Results. The agreement between both of the COL broth microdilution (BMD) methods was perfect (100/100). The gradient test and VITEK 2 analysis yielded comparable EA rates (92/100 and 72/79, respectively), with the latter not registering any very major errors (VMEs). The MVB gradient test achieved EA in 66 of 85 isolates and VITEK 2 in 70/85. For IRL, EA was reached in 69 and 64 of 85 cases by gradient test and VITEK 2 analysis, respectively. The ERV gradient test yielded false results in nearly all (12/15) CRABs but achieved EA in 46 of 50 CREs. The VITEK system recorded EA for ERV in 60 of 65 isolates. Conclusions. We observed substantial variability in the measured MICs between BMD and the alternative methods. In only a few constellations, VITEK 2 or gradient tests could substitute the reference method. BMD is the method of choice for COL analysis, with VITEK 2 representing an alternative method for CRPA testing. Alternative methods for MVB did not provide reliable results, except for Enterobacterales, when tested with the gradient test. However, resistant results need to be confirmed by BMD. Only BMD can be used for IRL MIC determination. VITEK 2 was mostly accurate in measuring ERV MICs, while the corresponding gradient test yielded reliable results exclusively in CREs. It is essential that laboratories are aware of which testing method provides reliable results for each combination of microorganisms and reserve antibiotics.
引用
收藏
页数:10
相关论文
共 34 条
[1]   Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City [J].
Abdallah, Marie ;
Olafisoye, Olawole ;
Cortes, Christopher ;
Urban, Carl ;
Landman, David ;
Quale, John .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) :1802-1805
[2]  
[Anonymous], 2017, Drug-Resistant Infections: A Threat to Our Economic Future, DOI DOI 10.1596/267
[3]  
[Anonymous], 2019, SUSCEPTIBILITY TESTI
[4]   Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci [J].
Blanchard, Laurine S. ;
Armstrong, Thomas P. ;
Kresken, Michael ;
Emery, Christopher L. ;
Ying, Yun X. ;
Sauvonnet, Veronique ;
Zambardi, Gilles .
JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (03) :e0165022
[5]  
Chew KL, 2017, J CLIN MICROBIOL, V55, P2609, DOI [10.1128/JCM.00268-17, 10.1128/jcm.00268-17]
[6]  
Clinical and Laboratory Standards Institute, 2015, Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, VM52
[7]   Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Kiebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates [J].
Dafopoulou, Konstantina ;
Zarkotou, Olympia ;
Dimitroulia, Evangelia ;
Hadjichristodoulou, Christos ;
Gennimata, Vasiliki ;
Pournaras, Spyros ;
Tsakris, Athanasios .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) :4625-4630
[9]   Multicenter Clinical Evaluation of Vitek 2 Meropenem-Vaborbactam for Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa [J].
Dwivedi, Hari P. ;
Franklin, Simone ;
Chandrasekaran, Sukantha ;
Garner, Omai ;
Traczewski, Maria M. ;
Beasley, Denise ;
Procop, Gary W. ;
Tuohy, Marion ;
Wilson, Deborah ;
Bala, Yohann ;
Pincus, David H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (01)
[10]  
EUCAST, European Committe on Antimicrobial Susceptibility Testing. Clinical breakpoints for fungi (Candida and Aspergillus species)